Increlex® clinical trials

Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

This study is a registry tracking the long-term safety and effectiveness of Increlex® in children and teenagers with a specific growth condition (SPIGFD). It involves collecting information from patients already using the medication to understand its real-world impact.